No supplier or customer ties in CRMD's filings yet. The map draws only what companies disclose to the SEC; ties named in other companies' filings join as the graph reads them.
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
Nothing on the wire mentions CRMD yet. Iris sweeps the public feeds every quarter hour; headlines land here the moment a sweep tags them.
How CRMD has moved on past release days vs its typical ±2.9% day, and how often it closed up. Computed from daily closes — not a forecast.